Dafpus GBS

You might also like

You are on page 1of 1

DAFTAR PUSTAKA

1. Bersano A, Carpo M, Allaria S, Franciotta D, Citterio A, Nobile-Orazio E.


Long term disability and social status change after Guillain-Barr
syndrome. J Neurol. 2006 Feb. 253(2):214-8
2. Mullings KR, Alleva JT, Hudgins TH. Rehabilitation of Guillain-Barr
syndrome. Dis Mon. 2010 May. 56(5):288-92
3. Hughes RA, Pritchard J, Hadden RD. Pharmacological treatment other
than corticosteroids, intravenous immunoglobulin and plasma exchange
for Guillain-Barr syndrome. Cochrane Database Syst Rev. 2013 Feb 28.
2:CD008630
4. Ferri FF. Ferri's Clinical Advisor 2014: 5 Books in 1. Philadelphia, Pa.:
Mosby Elsevier; 2014. https://www.clinicalkey.com. Accessed Sept 18,
2016.
5. Yuki N, Hartung HP. Guillain-Barr Syndrome. N Engl J Med. 2012;
366:2294-2304.
6. Van Doorn PA, Ruts L, Jacobs BC. Clinical Features, pathogenesis, and
treatment of Guillain-Barr Syndrome. Lancet Neurol. 2008; 7: 939-50.
7. Willison HJ, Jacobs BC, Van Doorn PA. Guillain-Barr syndrome. Lancet.
2016 February, 29; 388: 71727
8. Jacobs BC, Koga M, van Rijs W, Geleijns K, van Doorn PA, Willison HJ,
et al. Subclass IgG to motor gangliosides related to infection and clinical
course in Guillain-Barr syndrome. J Neuroimmunol. 2008 Feb. 194(12):181-90
9. Koga M, Takahashi M, Masuda M, Hirata K, Yuki N. Campylobacter gene
polymorphism as a determinant of clinical features of Guillain-Barr
syndrome. Neurology. 2005 Nov 8. 65(9):1376-81.
10. Geleijns K, Roos A, Houwing-Duistermaat JJ, van Rijs W, Tio-Gillen AP,
Laman JD, et al. Mannose-binding lectin contributes to the severity of
Guillain-Barr syndrome. J Immunol. 2006 Sep 15. 177(6):4211-7.
11. Aminoff MJ, Greenberg DA, Simon RP. Clinical neurology. 9th ed. Lange:
2015;307-9
12. Vucic S, Kiernan MC, Cornblath DR. Guillain-Barr syndrome: An
update. J Clin Neurosci 2009;16:733741
13.
Lidsay KW. Guillain-Barre Syndrome dalam Neurology and
Neurosurgery Illustrated. 5th ed. Elsevier: 2011; 422-5.

You might also like